Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study.

The article "Representation of women in randomized controlled trials of novel antidiabetic drugs: A cohort study" published in Diabetes, Obesity & Metabolism highlights the underrepresentation of women in clinical trials for diabetes drugs, impacting the precision of medical interventions. The study focused on trials with primary outcomes related to cardiac and renal events, revealing a significant lack of female participants. Despite efforts to reduce gender disparities in clinical research, women were notably underrepresented, affecting the accuracy of treatment practices. The study recommends future research prioritize recruiting women in proportions reflective of their representation in the population to enhance the relevance of medical interventions. [Extracted from the article]